— Know what they know.
Not Investment Advice

ASXC AMEX

Asensus Surgical, Inc.
1W: +24.2% 1M: +2.7% 3M: +40.3% 1Y: +24.8% 3Y: -83.3% 5Y: -97.3%
$0.35
Last traded 2024-08-21 — delisted
AMEX · Healthcare · Medical - Devices · $94.9M mcap · 246M float · 1.25% daily turnover

Cash Flow Trends

Operating Cash Flow
-$64M -8.0% ▼
Capital Expenditures
$561K +56.1% ▲
5Y CAGR: -6.1%
Free Cash Flow
-$64M -6.6% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +100.0% ▲
Net Change in Cash
$11M +191.1% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2019FY2020FY2021FY2022FY2023
— Operating Activities —
Net Income-$154M-$59M-$62M-$76M-$78M
Depreciation & Amort.$12M$14M$14M$11M$4M
Stock-Based Comp.$12M$8M$9M$8M$8M
Change in Working Capital-$13M-$11M$408K-$5M$3M
Other Non-Cash Items$73M$3M-$2M$2M-$52K
Operating Cash Flow-$73M-$47M-$41M-$59M-$64M
— Investing Activities —
Capital Expenditures-$437K-$3K-$1M-$1M-$561K
Acquisitions (Net)$16M$0$118M-$49M-$65M
Investment Purchases-$13M$0-$122M-$34M-$12M
Investment Sales$65M$0$4M$83M$77M
Other Investing$16M$0-$118M$49M$65M
Investing Cash Flow$68M-$3K-$120M$48M$65M
— Financing Activities —
Net Debt Issuance-$31M$3M$0$0$0
Stock Repurchased-$499K$0$0-$350K$0
Dividends Paid$0-$412K$0$0$0
Other Financing$26M$4M$30M-$332K-$492K
Financing Cash Flow-$6M$53M$162M-$332K$10M
Net Change in Cash-$11M$7M$2M-$12M$11M
Cash End of Period$11M$18M$19M$7M$17M
Free Cash Flow-$74M-$47M-$42M-$60M-$64M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms